{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T12:16:52Z","timestamp":1782476212044,"version":"3.54.5"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:00:00Z","timestamp":1711670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005972","name":"Stiftung Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["70113753"],"award-info":[{"award-number":["70113753"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FR 1241\/16-1"],"award-info":[{"award-number":["FR 1241\/16-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.phrs.2024.107165","type":"journal-article","created":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T16:31:46Z","timestamp":1711816306000},"page":"107165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Cardiomyocytes, cardiac endothelial cells and fibroblasts contribute to anthracycline-induced cardiac injury through RAS-homologous small GTPases RAC1 and CDC42"],"prefix":"10.1016","volume":"203","author":[{"given":"Pelin","family":"K\u00fcc\u00fck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Abbey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Henninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2024.107165_bib1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/1471-2407-10-337","article-title":"Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials","volume":"10","author":"Smith","year":"2010","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.phrs.2024.107165_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113480","article-title":"Anthracyclines as Topoisomerase II Poisons: From Early Studies to New Perspectives","volume":"19","author":"Marinello","year":"2018","journal-title":"Int J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.phrs.2024.107165_bib3","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.molcel.2007.11.015","article-title":"The DNA damage response: ten years after","volume":"28","author":"Harper","year":"2007","journal-title":"Mol. Cell"},{"issue":"21","key":"10.1016\/j.phrs.2024.107165_bib4","doi-asserted-by":"crossref","first-page":"6095","DOI":"10.1111\/febs.15583","article-title":"New insights into the activities and toxicities of the old anticancer drug doxorubicin","volume":"288","author":"van der Zanden","year":"2021","journal-title":"FEBS J."},{"issue":"7","key":"10.1016\/j.phrs.2024.107165_bib5","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/CIRCRESAHA.119.314681","article-title":"Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy","volume":"126","author":"Wallace","year":"2020","journal-title":"Circ. Res"},{"issue":"11","key":"10.1016\/j.phrs.2024.107165_bib6","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.15252\/embr.201439245","article-title":"Senescence and apoptosis: dueling or complementary cell fates?","volume":"15","author":"Childs","year":"2014","journal-title":"EMBO Rep."},{"issue":"18","key":"10.1016\/j.phrs.2024.107165_bib7","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1161\/01.CIR.0000146889.46519.27","article-title":"Modulation of doxorubicin-induced cardiac dysfunction in toll-like receptor-2-knockout mice","volume":"110","author":"Nozaki","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.phrs.2024.107165_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.418","article-title":"Statins in anthracycline-induced cardiotoxicity: Rac and Rho, and the heartbreakers","volume":"8","author":"Henninger","year":"2017","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.phrs.2024.107165_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.124","article-title":"Osteocrin attenuates inflammation, oxidative stress, apoptosis, and cardiac dysfunction in doxorubicin-induced cardiotoxicity","volume":"10","author":"Hu","year":"2020","journal-title":"Clin. Transl. Med"},{"issue":"2","key":"10.1016\/j.phrs.2024.107165_bib10","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41418-019-0372-z","article-title":"FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT","volume":"27","author":"Zhang","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.phrs.2024.107165_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101747","article-title":"Meteorin-like protein attenuates doxorubicin-induced cardiotoxicity via activating cAMP\/PKA\/SIRT1 pathway","volume":"37","author":"Hu","year":"2020","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107165_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cbi.2008.09.012","article-title":"Reactive oxygen species-independent apoptosis in doxorubicin-treated H9c2 cardiomyocytes: role for heme oxygenase-1 down-modulation","volume":"177","author":"Bernuzzi","year":"2009","journal-title":"Chem. Biol. Inter."},{"issue":"1-2","key":"10.1016\/j.phrs.2024.107165_bib13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11010-016-2653-x","article-title":"Oxidative stress does not play a primary role in the toxicity induced with clinical doses of doxorubicin in myocardial H9c2 cells","volume":"413","author":"Rharass","year":"2016","journal-title":"Mol. Cell Biochem"},{"issue":"11","key":"10.1016\/j.phrs.2024.107165_bib14","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.freeradbiomed.2003.08.005","article-title":"The oral iron chelator ICL670A (deferasirox) does not protect myocytes against doxorubicin","volume":"35","author":"Hasinoff","year":"2003","journal-title":"Free Radic. Biol. Med"},{"issue":"18","key":"10.1016\/j.phrs.2024.107165_bib15","doi-asserted-by":"crossref","first-page":"8839","DOI":"10.1158\/0008-5472.CAN-07-1649","article-title":"Topoisomerase IIbeta mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane","volume":"67","author":"Lyu","year":"2007","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.phrs.2024.107165_bib16","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.008209","article-title":"Clinically Translatable Prevention of Anthracycline Cardiotoxicity by Dexrazoxane Is Mediated by Topoisomerase II Beta and Not Metal Chelation","volume":"14","author":"Jirkovsky","year":"2021","journal-title":"Circ. Heart Fail"},{"key":"10.1016\/j.phrs.2024.107165_bib17","doi-asserted-by":"crossref","unstructured":"C.K. Tebbi, W.B. London, D. Friedman, D. Villaluna, P.A. De Alarcon, L.S. Constine, N.P. Mendenhall, R. Sposto, A. Chauvenet, C.L. Schwartz, Dexrazoxane-associated risk for acute myeloid leukemia\/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease, J Clin Oncol 25(5) (2007) 493-500, doi:25\/5\/493 [pii]10.1200\/JCO.2005.02.3879.","DOI":"10.1200\/JCO.2005.02.3879"},{"issue":"4","key":"10.1016\/j.phrs.2024.107165_bib18","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/annonc\/mdj134","article-title":"Multicenter randomized phase III study of the cardioprotective effect of dexrazoxane (Cardioxane) in advanced\/metastatic breast cancer patients treated with anthracycline-based chemotherapy","volume":"17","author":"Marty","year":"2006","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.phrs.2024.107165_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2011.65","article-title":"Inhibition of Rac1 signaling by lovastatin protects against anthracycline-induced cardiac toxicity","volume":"2","author":"Huelsenbeck","year":"2011","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.phrs.2024.107165_bib20","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.yjmcc.2009.07.024","article-title":"Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity","volume":"47","author":"Yoshida","year":"2009","journal-title":"J. Mol. Cell Cardiol."},{"issue":"9","key":"10.1016\/j.phrs.2024.107165_bib21","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jacc.2011.05.025","article-title":"Efficiency of atorvastatin in the protection of anthracycline-induced cardiomyopathy","volume":"58","author":"Acar","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107165_bib22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","article-title":"Pleiotropic Effects of Statins on the Cardiovascular System","volume":"120","author":"Oesterle","year":"2017","journal-title":"Circ. Res"},{"key":"10.1016\/j.phrs.2024.107165_bib23","doi-asserted-by":"crossref","unstructured":"J. Ma, Y. Wang, D. Zheng, M. Wei, H. Xu, T. Peng, Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways, Cardiovasc Res 97(1) (2013) 77-87, doi:cvs309 [pii]robo10.1093\/cvr\/cvs309.","DOI":"10.1093\/cvr\/cvs309"},{"issue":"4","key":"10.1016\/j.phrs.2024.107165_bib24","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1161\/01.RES.0000204727.46710.5e","article-title":"Regulation of NADPH oxidases: the role of Rac proteins","volume":"98","author":"Hordijk","year":"2006","journal-title":"Circ. Res"},{"issue":"7","key":"10.1016\/j.phrs.2024.107165_bib25","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0092-8674(05)80018-2","article-title":"The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK\/SAPK signaling pathway","volume":"81","author":"Coso","year":"1995","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.phrs.2024.107165_bib26","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1101\/gad.11.4.463","article-title":"Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins","volume":"11","author":"Perona","year":"1997","journal-title":"Genes Dev."},{"issue":"5489","key":"10.1016\/j.phrs.2024.107165_bib27","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1126\/science.290.5489.144","article-title":"Regulation of STAT3 by direct binding to the Rac1 GTPase","volume":"290","author":"Simon","year":"2000","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.phrs.2024.107165_bib28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.taap.2012.03.012","article-title":"The lipid lowering drug lovastatin protects against doxorubicin-induced hepatotoxicity","volume":"261","author":"Henninger","year":"2012","journal-title":"Toxicol. Appl. Pharm."},{"key":"10.1016\/j.phrs.2024.107165_bib29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.phrs.2014.11.003","article-title":"Chronic heart damage following doxorubicin treatment is alleviated by lovastatin","volume":"91","author":"Henninger","year":"2015","journal-title":"Pharm. Res"},{"issue":"8","key":"10.1016\/j.phrs.2024.107165_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2011.65","article-title":"Inhibition of Rac1 signaling by lovastatin protects against anthracycline-induced cardiac toxicity","volume":"2","author":"Huelsenbeck","year":"2011","journal-title":"Cell Death Dis."},{"issue":"20","key":"10.1016\/j.phrs.2024.107165_bib31","doi-asserted-by":"crossref","first-page":"7618","DOI":"10.1073\/pnas.0307512101","article-title":"Rational design and characterization of a Rac GTPase-specific small molecule inhibitor","volume":"101","author":"Gao","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"49","key":"10.1016\/j.phrs.2024.107165_bib32","doi-asserted-by":"crossref","first-page":"35666","DOI":"10.1074\/jbc.M703571200","article-title":"Specificity and mechanism of action of EHT 1864, a novel small molecule inhibitor of Rac family small GTPases","volume":"282","author":"Shutes","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"46","key":"10.1016\/j.phrs.2024.107165_bib33","doi-asserted-by":"crossref","first-page":"38590","DOI":"10.1074\/jbc.M112.377903","article-title":"Rac1 protein signaling is required for DNA damage response stimulated by topoisomerase II poisons","volume":"287","author":"Huelsenbeck","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2024.107165_bib34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00204-017-2017-7","article-title":"Rac1-mediated cardiac damage causes diastolic dysfunction in a mouse model of subacute doxorubicin-induced cardiotoxicity","volume":"92","author":"Ohlig","year":"2018","journal-title":"Arch. Toxicol."},{"issue":"12","key":"10.1016\/j.phrs.2024.107165_bib35","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1016\/j.bbamcr.2013.08.016","article-title":"DNA damage response (DDR) induced by topoisomerase II poisons requires nuclear function of the small GTPase Rac","volume":"1833","author":"Wartlick","year":"2013","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.phrs.2024.107165_bib36","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bcp.2019.03.038","article-title":"Distinct contribution of Rac1 expression in cardiomyocytes to anthracycline-induced cardiac injury","volume":"164","author":"Henninger","year":"2019","journal-title":"Biochem Pharm."},{"issue":"4","key":"10.1016\/j.phrs.2024.107165_bib37","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41419-021-03614-x","article-title":"Regulated cell death pathways in doxorubicin-induced cardiotoxicity","volume":"12","author":"Christidi","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2024.107165_bib38","doi-asserted-by":"crossref","unstructured":"W.C. Claycomb, N.A. Lanson, Jr., B.S. Stallworth, D.B. Egeland, J.B. Delcarpio, A. Bahinski, N.J. Izzo, Jr, HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte, Proc Natl Acad Sci U S A 95(6) (1998) 2979-2984, doi:10.1073\/pnas.95.6.2979.","DOI":"10.1073\/pnas.95.6.2979"},{"issue":"15","key":"10.1016\/j.phrs.2024.107165_bib39","doi-asserted-by":"crossref","first-page":"7291","DOI":"10.1073\/pnas.91.15.7291","article-title":"Progressive growth in immunodeficient mice and host cell recruitment by mouse endothelial cells transformed by polyoma middle-sized T antigen: implications for the pathogenesis of opportunistic vascular tumors","volume":"91","author":"Garlanda","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.phrs.2024.107165_bib40","doi-asserted-by":"crossref","first-page":"H1667","DOI":"10.1152\/ajpheart.01144.2007","article-title":"Blebbistatin extends culture life of adult mouse cardiac myocytes and allows efficient and stable transgene expression","volume":"294","author":"Kabaeva","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2024.107165_bib41","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0091-679X(04)75014-1","article-title":"Detection of DNA damage in individual cells by analysis of histone H2AX phosphorylation","author":"Olive","year":"2004","journal-title":"Methods Cell Biol. 75"},{"issue":"10","key":"10.1016\/j.phrs.2024.107165_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2022.119320","article-title":"Nuclear RAC1 is a modulator of the doxorubicin-induced DNA damage response","volume":"1869","author":"Kitzinger","year":"2022","journal-title":"Biochim Biophys. Acta Mol. Cell Res"},{"issue":"7","key":"10.1016\/j.phrs.2024.107165_bib43","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0006-2952(98)00307-4","article-title":"A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin","volume":"57","author":"Gewirtz","year":"1999","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.phrs.2024.107165_bib44","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.phrs.2017.03.016","article-title":"Doxorubicin targets multiple players: A new view of an old problem","volume":"127","author":"Cappetta","year":"2018","journal-title":"Pharm. Res"},{"issue":"7","key":"10.1016\/j.phrs.2024.107165_bib45","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.cell.2015.05.026","article-title":"Dynamics of Cell Generation and Turnover in the Human Heart","volume":"161","author":"Bergmann","year":"2015","journal-title":"Cell"},{"issue":"46","key":"10.1016\/j.phrs.2024.107165_bib46","doi-asserted-by":"crossref","first-page":"13144","DOI":"10.1073\/pnas.1616168113","article-title":"VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection","volume":"113","author":"Rasanen","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.phrs.2024.107165_bib47","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1073\/pnas.0830918100","article-title":"Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses","volume":"100","author":"Rothkamm","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7267","key":"10.1016\/j.phrs.2024.107165_bib48","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nature08467","article-title":"The DNA-damage response in human biology and disease","volume":"461","author":"Jackson","year":"2009","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2024.107165_bib49","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nrm1546","article-title":"p53: traffic cop at the crossroads of DNA repair and recombination","volume":"6","author":"Sengupta","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.phrs.2024.107165_bib50","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/sj.cdd.4401267","article-title":"Lack of Apaf-1 expression confers resistance to cytochrome c-driven apoptosis in cardiomyocytes","volume":"10","author":"Sanchis","year":"2003","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.phrs.2024.107165_bib51","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1474-9726.2007.00358.x","article-title":"Induction of premature senescence in cardiomyocytes by doxorubicin as a novel mechanism of myocardial damage","volume":"7","author":"Maejima","year":"2008","journal-title":"Aging Cell"},{"issue":"20","key":"10.1016\/j.phrs.2024.107165_bib52","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1038\/sj.onc.1203553","article-title":"Extinction of rac1 and Cdc42Hs signalling defines a novel p53-dependent apoptotic pathway","volume":"19","author":"Lassus","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2024.107165_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118468","article-title":"Rac1 silencing, NSC23766 and EHT1864 reduce growth and actin organization of bladder smooth muscle cells","volume":"261","author":"Wang","year":"2020","journal-title":"Life Sci."},{"issue":"11","key":"10.1016\/j.phrs.2024.107165_bib54","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1093\/carcin\/bgp235","article-title":"The Rac1\/MKK7\/JNK pathway signals upregulation of Atg5 and subsequent autophagic cell death in response to oncogenic Ras","volume":"30","author":"Byun","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.phrs.2024.107165_bib55","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6138941","article-title":"Downregulation of MCF2L Promoted the Ferroptosis of Hepatocellular Carcinoma Cells through PI3K\/mTOR Pathway in a RhoA\/Rac1 Dependent Manner","volume":"2022","author":"Huang","year":"2022","journal-title":"Dis. Markers"},{"issue":"43","key":"10.1016\/j.phrs.2024.107165_bib56","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1038\/onc.2012.640","article-title":"Senescence and aging: the critical roles of p53","volume":"32","author":"Rufini","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2024.107165_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrrev.2015.07.001","article-title":"Persistent gammaH2AX: A promising molecular marker of DNA damage and aging","volume":"766","author":"Siddiqui","year":"2015","journal-title":"Mutat. Res Rev. Mutat. Res"},{"issue":"8","key":"10.1016\/j.phrs.2024.107165_bib58","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/ncb1909","article-title":"Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion","volume":"11","author":"Rodier","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.phrs.2024.107165_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fragi.2022.1058435","article-title":"Anthracycline-induced cardiotoxicity and senescence","volume":"3","author":"Booth","year":"2022","journal-title":"Front Aging"},{"issue":"2","key":"10.1016\/j.phrs.2024.107165_bib60","doi-asserted-by":"crossref","first-page":"C380","DOI":"10.1152\/ajpcell.00073.2019","article-title":"Accelerated cardiomyocyte senescence contributes to late-onset doxorubicin-induced cardiotoxicity","volume":"318","author":"Mitry","year":"2020","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"16","key":"10.1016\/j.phrs.2024.107165_fur1","doi-asserted-by":"crossref","first-page":"13228","DOI":"10.1074\/jbc.M111.334524","article-title":"Characterization of EHop-016, novel small molecule inhibitor of Rac GTPase","volume":"287","author":"Montalvo-Ortiz","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.phrs.2024.107165_fur2","doi-asserted-by":"crossref","first-page":"8531","DOI":"10.1074\/jbc.M112.435941","article-title":"Characterization of a Cdc42 protein inhibitor and its use as a molecular probe","volume":"288","author":"Hong","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.phrs.2024.107165_fur3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074924","article-title":"A Rac1\/Cdc42 GTPase-specific small molecule inhibitor suppresses growth of primary human prostate cancer xenografts and prolongs survival in mice","volume":"8","author":"Zins","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.phrs.2024.107165_fur4","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.chembiol.2012.05.009","article-title":"Rational design of small molecule inhibitors targeting RhoA subfamily Rho GTPases","volume":"19","author":"Shang","year":"2012","journal-title":"Chem. Biol."},{"issue":"5","key":"10.1016\/j.phrs.2024.107165_fur5","first-page":"976","article-title":"Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases","volume":"57","author":"Ishizaki","year":"2000","journal-title":"Mol. Pharm."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824001099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824001099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T03:35:45Z","timestamp":1714275345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661824001099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":65,"alternative-id":["S1043661824001099"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107165","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiomyocytes, cardiac endothelial cells and fibroblasts contribute to anthracycline-induced cardiac injury through RAS-homologous small GTPases RAC1 and CDC42","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107165","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107165"}}